High Court Restrains Zydus Life from Launching Dabrafenib Drug

⚖️

has been barred by a High Court from launching a Dabrafenib-containing drug, with the compound covered under a patent held by Novartis. The order prevents Zydus from commercialising the product, potentially delaying its market launch.